AssetMark Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$336K Buy
20,075
+11,613
+137% +$195K ﹤0.01% 1112
2025
Q1
$130K Buy
8,462
+3,257
+63% +$50.1K ﹤0.01% 1228
2024
Q4
$115K Buy
5,205
+4,851
+1,370% +$107K ﹤0.01% 1215
2024
Q3
$6.38K Sell
354
-192
-35% -$3.46K ﹤0.01% 1703
2024
Q2
$8.87K Buy
+546
New +$8.87K ﹤0.01% 1518
2019
Q3
Sell
-1,512
Closed -$14K 1419
2019
Q2
$14K Sell
1,512
-36
-2% -$333 ﹤0.01% 939
2019
Q1
$24K Sell
1,548
-100
-6% -$1.55K ﹤0.01% 845
2018
Q4
$25K Sell
1,648
-800
-33% -$12.1K ﹤0.01% 839
2018
Q3
$53K Sell
2,448
-120
-5% -$2.6K ﹤0.01% 730
2018
Q2
$62K Buy
2,568
+954
+59% +$23K ﹤0.01% 676
2018
Q1
$28K Sell
1,614
-297
-16% -$5.15K ﹤0.01% 884
2017
Q4
$36K Sell
1,911
-64
-3% -$1.21K ﹤0.01% 862
2017
Q3
$35K Sell
1,975
-999
-34% -$17.7K ﹤0.01% 786
2017
Q2
$99K Buy
2,974
+1,020
+52% +$34K ﹤0.01% 554
2017
Q1
$63K Sell
1,954
-2,173
-53% -$70.1K ﹤0.01% 593
2016
Q4
$150K Sell
4,127
-1,072
-21% -$39K ﹤0.01% 443
2016
Q3
$239K Sell
5,199
-595
-10% -$27.4K ﹤0.01% 374
2016
Q2
$291K Buy
5,794
+719
+14% +$36.1K ﹤0.01% 353
2016
Q1
$272K Sell
5,075
-26,669
-84% -$1.43M ﹤0.01% 343
2015
Q4
$2.08M Buy
31,744
+14,403
+83% +$946K 0.04% 210
2015
Q3
$979K Sell
17,341
-28,209
-62% -$1.59M 0.02% 238
2015
Q2
$2.69M Sell
45,550
-2,424
-5% -$143K 0.06% 151
2015
Q1
$2.99M Sell
47,974
-2,213
-4% -$138K 0.06% 130
2014
Q4
$2.89M Buy
50,187
+16,705
+50% +$961K 0.06% 146
2014
Q3
$1.8M Sell
33,482
-1,610
-5% -$86.6K 0.04% 220
2014
Q2
$1.84M Sell
35,092
-4,333
-11% -$227K 0.04% 218
2014
Q1
$2.08M Sell
39,425
-1,885
-5% -$99.6K 0.05% 152
2013
Q4
$1.66M Sell
41,310
-4,167
-9% -$167K 0.04% 196
2013
Q3
$1.72M Buy
+45,477
New +$1.72M 0.04% 193